Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: The DREAMseq Trial – ECOG-ACRIN EA6134 - Atkins, MB; Lee, SJ; Chmielowski, B (J Clin Oncol, 2023)